BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2019 8:57:04 AM | Browse: 1392 | Download: 2898
Publication Name World Journal of Cardiology
Manuscript ID 47649
Country India
ISSN 1949-8462 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019 Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac & Cardiovascular Systems
Manuscript Type Retrospective Study
Article Title One-year outcomes of a NeoHexa sirolimus-eluting coronary stent system with a biodegradable polymer in all-comers coronary artery disease patients: Results from NeoRegistry in India
Manuscript Source Unsolicited Manuscript
All Author List Rajagopal Jambunathan, Dinesh Basavanna, Preeti Vani, Malte Neuss and Prashant Jandandhu
ORCID
Author(s) ORCID Number
Rajagopal Jambunathan http://orcid.org/0000-0001-7969-3564
Dinesh Basavanna http://orcid.org/0000-0003-0361-5441
Preeti Vani http://orcid.org/0000-0001-5665-1062
Malte Neuss http://orcid.org/0000-0003-3046-4140
Prashant Jandandhu http://orcid.org/0000-0001-5816-4006
Funding Agency and Grant Number
Funding Agency Grant Number
the Sahajanand Laser Technology Ltd., India
Corresponding Author Prashant Jandandhu, MSc, Medical Division, Sahajanand Laser Technology Ltd., Gandhinagar 382027, Gujarat, India. clinical@sltl.com
Key Words Sirolimus; Drug-eluting stent; Myocardial infarction; Thrombosis; Coronary artery disease;
Core Tip Reports have indicated the use of stents in patients with coronary artery disease has reduced the rates of restenosis. Biodegradable polymer drug eluting stents, have shown to reduce restenosis rates and lower the stent thrombosis rate. Our study assessed 1-year, single-center cohort for clinical outcomes of patients who had received NeoHexa sirolimus drug-eluting stents in real practice. It showed relatively low rates of major adverse cardiac event and stent thrombosis supporting safety and performance of NeoHexa stent and supporting its use as an effective alternative to other existing stents.
Publish Date 2019-08-22 08:57
Citation Jambunathan R, Basavanna D, Vani P, Neuss M, Janbandhu P. One-year outcomes of a NeoHexa sirolimus-eluting coronary stent system with a biodegradable polymer in all-comers coronary artery disease patients: Results from NeoRegistry in India. World J Cardiol 2019; 11(8): 200-208
URL https://www.wjgnet.com/1949-8462/full/v11/i8/200.htm
DOI https://dx.doi.org/10.4330/wjc.v11.i8.200
Full Article (PDF) WJC-11-200.pdf
Full Article (Word) WJC-11-200.docx